Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Endo determined to discontinue its registries and the GRASP registry enrollment has been closed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Pulse Infoframe | INDUSTRY |
This is an observational study, meaning participants will not receive any investigational treatment as part of this study.
Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.
Each participant of the study will have their data collected from the date of confirmed diagnosis of DC to the date of enrollment in the registry, post consent. Data will be collected from the participants clinical records as well as from the participant directly. Data will be collected through Pulse Infoframe's technology platform.
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants Receiving Each Treatment Type for DC | Up to 36 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline in Michigan Hand Questionnaire (MHQ) Scale Score | Up to 36 months | |
| Change from Baseline in European Quality of Life Five Dimension (EQ-5D) Questionnaire Score | Up to 36 months |
Not provided
Key Inclusion Criteria:
Key Exclusion criteria:
Not provided
Not provided
Not provided
Participants with a confirmed diagnosis of DC will be enrolled in the United States.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Information | Endo USA Inc., a Keenova Therapeutics Company | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Endo Pharmaceuticals Clinical Site 6 | Phoenix | Arizona | 85015 | United States | ||
| Endo Pharmaceuticals Clinical Site 5 |
Not provided
| ID | Term |
|---|---|
| D004387 | Dupuytren Contracture |
| ID | Term |
|---|---|
| D005350 | Fibroma |
| D018218 | Neoplasms, Fibrous Tissue |
| D009372 | Neoplasms, Connective Tissue |
| D018204 | Neoplasms, Connective and Soft Tissue |
Not provided
Not provided
Not provided
Not provided
Not provided
| Change from Baseline in Unité Rhumatologique des Affections de la Main (URAM) Scale Score | Up to 36 months |
| Participant Satisfaction Questionnaire | Up to 36 months |
| Number of Participants Receiving Post-Procedural Care by the Treating Physician | Up to 36 months |
| Greenwich |
| Connecticut |
| 06831 |
| United States |
| Endo Pharmaceuticals Clinical Site 4 | Temple Terrace | Florida | 33637 | United States |
| Endo Pharmaceuticals Clinical Site 2 | Indianapolis | Indiana | 46260 | United States |
| Endo Pharmaceuticals Clinical Site 1 | Eatontown | New Jersey | 07774 | United States |
| Endo Pharmaceuticals Clinical Site 7 | Charlotte | North Carolina | 28207 | United States |
| Endo Pharmaceuticals Clinical Site 3 | Bend | Oregon | 97701 | United States |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D003286 | Contracture |
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |